WATCH: Life Healthcare shareholders in for bumper payday

Business Day TV talks to Life Healthcare CEO Peter Wharton-Hood

Eli Lilly needs approval for injection pen use in UK for weight-loss drug

Lilly says the injection device in question will be different from the pen Lilly plans to use for the weight-loss drug in the US

AstraZeneca raises profit outlook

Strong sales of cancer treatments offsets loss of Covid-19 vaccine sales

SA’s private healthcare system luring expats back, says Discovery CEO

Discovery CEO says if the National Health Insurance bill is enacted as it stands, it will harm the thriving private healthcare system.

Activist investor Elliott has drugmaker BioMarin in its sights

Shares rise on report Elliott has spent more than $1bn on a stake in the pharma company

Smith & Nephew posts rosy update

Orthopaedics is its largest product segment and could benefit from powerful weight-loss drugs as more overweight people become more eligible for a knee ...

Ambledown boosts cancer coverage in gap policies

SPONSORED | The health insurance product provider addresses Africa’s cancer crisis with progressive, comprehensive gap cover solutions

Pfizer earnings weighed down by slump in demand for Covid shots

Drugmaker looks beyond vaccine as it reports quarterly loss on Paxlovid charge

PODCAST | Deputy CEO Whelan unpacks new Discovery Health app

Our host Mudiwa Gavaza is joined by Ronald Whelan, deputy CEO of Discovery Health

Aspen boss Stephen Saad says rollout of ARVs is a career highlight

Saad says he's proud that drug maker he cofounded was at the forefront of helping millions of patients

Sanofi loses $21bn in market value after scrapping profit target

But CEO Paul Hudson says the core innovative drugs business has improved enough to soon do without the more predictable cash flows from consumer products

Life Healthcare notes growth in revenue but fall in profit

Most of its divisions are growing with the number of patient days in its hospitals up by 10.2%

Merck enters cancer drug deal with Japanese firm

Drugmaker to pay Daiichi Sankyo $4bn up front and $1.5bn in payments over the next two years

WATCH: SA’s universal healthcare plan in focus

Business Day TV talks to Rich Sacini, president  of  health trade union Haitu

WATCH: Primary Health Properties eyes JSE listing

Business Day TV talks to Primary Health Property CEO  Harry Hyman